Lupin Of India, Forest Of U.S. Allies To Market Medical Devices In U.S.
This article was originally published in PharmAsia News
India's Lupin Laboratories and Forest Laboratories of the U.S. have agreed to share promotion and marketing of one of Lupin's medical devices in the United States. Forest's 50-person sales force is to be tapped to promote Lupin's Aerochamber products, such as AerochamberPlus, a valved holding chamber device with metered dose inhalers, to pediatricians. Lupin seeks to expand its presence in the U.S. respiratory market. (Click here for more
You may also be interested in...
Perrigo is latest consumer health firm to note substantially slower flu rates slammed OTC drug sales during 2020 fourth quarter. Its total cough/cold product sales for the year were off $63m on decreases of $34m in the Americas and $29m in its international markets.
In deal with Altaris Capital, “I don't feel like we got out at any cost,” says Perrigo CEO Murray Kessler. Agreement calls for “a number of mutual long-term relationship components ... including on Rx-to-OTC switches."
FDA and CDC advisory committee members wonder how to use the single-shot J&J vaccine if an ongoing study shows two doses are better than one.